Free Trial
OTCMKTS:BTCA

Bactolac Pharmaceutical (BTCA) Stock Price, News & Analysis

Bactolac Pharmaceutical logo
$120,000.00 0.00 (0.00%)
As of 09/18/2017

About Bactolac Pharmaceutical Stock (OTCMKTS:BTCA)

Key Stats

Today's Range
$120,000.00
▼
$120,000.00
50-Day Range
$120,000.00
▼
$120,000.00
52-Week Range
$120,000.00
▼
$120,000.00
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bactolac Pharmaceutical, Inc. is a contract manufacturer of dietary supplements and nutritional products. The company provides private-label and custom manufacturing services for brands seeking to develop, produce, package and distribute supplement products.

Its capabilities include formulation and product development, manufacturing of tablets, capsules, powders and other supplement formats, packaging, labeling and quality-control support. Bactolac serves customers in the health, wellness and consumer-products markets, helping them bring vitamins, minerals, herbal supplements and other nutritional products to market.

The company is based in the United States and has historically operated as a full-service supplement manufacturing partner. Publicly available information about its current leadership, detailed operating history and geographic customer base is limited.

AI Generated. May Contain Errors.

Receive BTCA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bactolac Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BTCA Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

BTCA Stock Analysis - Frequently Asked Questions

Bactolac Pharmaceutical's stock was trading at $120,000.00 on January 1st, 2026. Since then, BTCA shares have increased by 0.0% and is now trading at $120,000.00.

Company Calendar

Today
10/15/2026
Fiscal Year End
9/30/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Drugs, Proprietaries, & Sundries
Sub-Industry
N/A
Current Symbol
OTCMKTS:BTCA
CIK
N/A
Fax
N/A
Employees
126
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
0.01
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (OTCMKTS:BTCA) was last updated on 9/18/2017 by MarketBeat.com Staff.
From Our Partners